Td Asset Management Inc Allogene Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 677,140 shares of ALLO stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

677,140

Previous 799,340 15.29%

Holding current value

$1.54 Million

Previous $1.86 Million 1.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$2.08 - $3.5 $254,176 - $427,700	-122,200 Reduced 15.29%	677,140 $1.9 Million
Q2 2024 Aug 02, 2024	BUY	$2.23 - $4.38 $807,045 - $1.59 Million	361,904 Added 82.73%	799,340 $1.86 Million
Q1 2024 May 08, 2024	BUY	$2.92 - $5.63 $582,832 - $1.12 Million	199,600 Added 83.92%	437,436 $1.96 Million
Q3 2023 Oct 27, 2023	BUY	$3.17 - $5.96 $121,591 - $228,607	38,357 Added 19.23%	237,836 $753,000
Q2 2023 Aug 09, 2023	BUY	$4.53 - $6.74 $116,874 - $173,892	25,800 Added 14.85%	199,479 $991,000
Q4 2022 Feb 06, 2023	BUY	$5.62 - $11.11 $50,580 - $99,990	9,000 Added 5.47%	173,679 $1.09 Million
Q3 2022 Nov 07, 2022	BUY	$10.32 - $17.28 $378,805 - $634,279	36,706 Added 28.68%	164,679 $1.7 Million
Q2 2022 Aug 04, 2022	BUY	$6.78 - $12.28 $37,968 - $68,768	5,600 Added 4.58%	127,973 $1.46 Million
Q1 2022 May 10, 2022	BUY	$7.65 - $15.29 $100,980 - $201,828	13,200 Added 12.09%	122,373 $1.12 Million
Q4 2021 Feb 10, 2022	SELL	$13.13 - $24.52 $28,780 - $53,747	-2,192 Reduced 1.97%	109,173 $1.63 Million
Q3 2021 Nov 09, 2021	BUY	$21.01 - $27.64 $413,665 - $544,203	19,689 Added 21.48%	111,365 $2.86 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $238,916 - $364,121	10,171 Added 12.48%	91,676 $2.01 Million
Q1 2021 May 14, 2021	BUY	$25.79 - $39.02 $93,669 - $141,720	3,632 Added 4.66%	81,505 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $4,846 - $8,342	192 Added 0.25%	77,873 $1.97 Million
Q3 2020 Nov 10, 2020	SELL	$32.38 - $44.96 $155,424 - $215,808	-4,800 Reduced 5.82%	77,681 $2.93 Million
Q2 2020 Aug 13, 2020	BUY	$18.39 - $54.04 $518,708 - $1.52 Million	28,206 Added 51.97%	82,481 $3.53 Million
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $65,592 - $101,700	-3,600 Reduced 6.22%	54,275 $1.06 Million
Q2 2019 Aug 01, 2019	BUY	$25.56 - $31.09 $823,849 - $1 Million	32,232 Added 125.7%	57,875 $1.55 Million
Q1 2019 May 08, 2019	BUY	$24.82 - $32.54 $14,892 - $19,524	600 Added 2.4%	25,643 $741,000
Q4 2018 Feb 01, 2019	BUY	$22.5 - $33.3 $563,467 - $833,931	25,043 New	25,043 $674,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Allogene Therapeutics, Inc. Transaction History